|
FDA Approves Effient to Reduce the Risk of Heart Attack in Angioplasty Patients |
|
Written by IV Post
|
|
Monday, 13 July 2009 |
|
Washington, DC - The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.
|
|
Read more...
|
|
|
FDA Takes Enforcement Action Against Dietary Supplement and Protein Powder Manufacturers |
|
Written by IV Post
|
|
Monday, 13 July 2009 |
|
Washington, DC - The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Quality Formulation Laboratories, Inc., American Sports Nutrition Inc., Sports Nutrition International LLC and Mohamed S. Desoky, who oversees operations at all three companies.
|
|
Read more...
|
|
|
Research May Hold Key to Maintaining Embryonic Stem Cells in Lab |
|
Written by UT Southwestern
|
|
Friday, 10 July 2009 |
Dallas, Texas - In a new study that could transform embryonic stem cell (ES cell) research, scientists at UT Southwestern Medical Center have discovered why mouse ES cells can be easily grown in a laboratory while other mammalian ES cells are difficult, if not impossible, to maintain.
|
|
Read more...
|
|
|
Alzheimer's Research Pinpoints Antibodies that may Prevent Disease |
|
Written by IV Post
|
|
Friday, 10 July 2009 |
|
Stanford, California - Antibodies to a wide range of substances that can aggregate to form plaques, such as those found in Alzheimer’s patients, have been identified in the blood and cerebrospinal fluid of healthy people. Levels of these antibodies decline with age and, in Alzheimer’s patients, with increasing progression of the disease. |
|
Read more...
|
|
|
NIH Stem Cell Rules Seriously Flawed - Stanford Expert Irving Weissman Explains |
|
Written by Krista Conger - Stanford
|
|
Friday, 10 July 2009 |
|
Stanford, California - The National Institutes of Health released their final guidelines detailing what types of human embryonic stem cell research will qualify for federal funding. Although the rules permit federal funding of research on embryonic stem cell lines produced from excess early embryos from in vitro fertilization clinics, they disallow federal support of two key techniques used to derive embryonic stem cells in animals: that of transferring the genetic material from one cell into an egg without a nucleus, and that of stimulating an unfertilized egg to divide. |
|
Read more...
|
|
|
Tailoring Surgical Glues for Specific Applications |
|
Written by Elizabeth A. Thomson - MIT
|
|
Thursday, 09 July 2009 |
|
Cambridge, Massachusetts - Surgical adhesives, which can be used to seal tissues after an operation or to repair wounds, are becoming increasingly important parts of a doctor's toolkit. However, their one-size-fits-all nature means that existing adhesives, or glues, work well in some cases but not in others. |
|
Read more...
|
|
|
Racial Disparities in Breast Cancer Mortality Are Not Driven by Estrogen Receptor Status Alone |
|
Written by NIH
|
|
Thursday, 09 July 2009 |
|
Washington, DC - Black women who are diagnosed with breast cancer have a higher probability of dying from the disease than white women, regardless of their estrogen receptor status, according to research from the National Cancer Institute (NCI), part of the National Institutes of Health. |
|
Last Updated ( Thursday, 09 July 2009 )
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 49 - 60 of 682 |
